Friday, 22 February 2019

Third Point claims 300 percent return on activism since 2011

Reuters.com Newsletter

Third Point claims 300 percent return on activism since 2011

Pushing companies to perform better has earned Third Point a 300 percent return in the last eight years, the hedge fund told investors in a letter on Thursday, praising management at some of its targets for taking the right steps.

Hedge funds hunt for shipping debt in new market push

(Corrects Feb. 20 story to remove incorrect reference to sale of loans by Varde and Oakhill)

How personal finance guru Jill Schlesinger got smart about money

Jill Schlesinger got her start on Wall Street, and that is where she learned a lot of what she knows about the financial world. But she has built a career dishing out personal finance advice by pulling back the curtain on myths about investing, and showing how average people can make a solid plan for retirement.

UBS to appeal after fined 4.5 billion euros in French tax fraud case

A French court found Swiss bank UBS AG guilty of illegally soliciting clients and laundering the proceeds of tax evasion, ordering it to pay 4.5 billion euros ($5.1 billion) in penalties.

UBS CEO says French appeals process to take 'several years'

UBS Group expects its appeal of a French court verdict ordering the Swiss bank to pay 4.5 billion euros ($5.10 billion) for aiding tax evasion to last years, Chief Executive Sergio Ermotti told staff in a memo.

Buffett's Suncor bet to revive investor interest in Canadian energy

Berkshire Hathaway Inc's re-investment in Suncor Energy Inc highlights the benefits of being an integrated oil company and could revive investor interest in the languishing Canadian energy sector, fund managers said.

Stretch your retirement with this tax-saving strategy

Retirement strategy is about more than just how you will spend the money you have saved – it matters where that money is coming from too.

Bristol-Myers says Starboard nominated five directors, bought shares

Bristol-Myers Squibb Co said on Wednesday that activist hedge fund Starboard Value LP intends to nominate five directors to the U.S. drugmaker's board, one month after it announced a $74 billion deal to acquire peer Celgene Corp.

Related Videos

Brexit takes a bite out of Barclays earnings

U.S., China sketch outlines for trade deal

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS